Luis Gutiérrez-Rojas

28PUBLICATIONS
58CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsEpidemiological methodsPharmacogenomicsPhylogeny and comparative analysisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Mar 28, 2026
Prognostic Biomarkers and Precision Psychiatry: A Review of the Available Evidence.

Itziar María Béjar-Botello, Sara Jiménez-Fernández, Gloria Pérez-Guerrero

|Mar 21, 2026
Esketamine nasal spray for treatment-resistant depression: A retrospective multicenter real-world cohort study on effectiveness and suicidal outcomes.

J García-Jiménez, D Nuñez-Arias, G Carretero Merelo

|Feb 27, 2026
Understanding Adherence to Duloxetine in Psychiatric Practice: A Cross-Sectional Evaluation of Clinicians' Experience.

Cielo García-Montero, Óscar Fraile-Martínez, Juan Pablo Chart-Pascual

|Jan 12, 2026
Enhanced Bilateral Accelerated Theta Burst Stimulation for Comorbid Anxiety and Depressive Disorders: The Seville Protocol.

Á Moleón-Ruiz, P Álvarez de Toledo, L García-Fernández

|Aug 14, 2025
Cytisinicline vs. Varenicline in Tobacco Addiction: A Literature Review Focused on Emotional Regulation, Psychological Symptoms, and Mental Health.

Óscar Fraile-Martínez, Cielo García-Montero, Miguel A Ortega

|Aug 08, 2024
Compassionate use of esketamine intranasal in patients with severe major depressive disorder resistant to the treatment.

Luis Gutiérrez-Rojas, Julia Vendrell-Serres, J Antoni Ramos-Quiroga

Pageof 5